Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta

NCT01745185 · clinicaltrials.gov ↗
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

O & O Alpan LLC